Featured Public Outreach Success Story Technology

Are mRNA vaccines the future of cancer therapy?

Screenshot
RNA Canada ARN Board of Director member and McGill University’s Chair of the Department of Biochemistry, Dr. Thomas Duchaine, recently gave an exciting podcast with Dr. Ramy Saleh on the future of mRNA cancer vaccines.  These new technologies represent a major RNA-based technological advance that will become an important new class of personalized cancer therapy.  Professor Duchaine is also part of McGill’s DNA to RNA research and funding initiative, D2R, the mRNA Therapeutics Platform and the Goodman Cancer Institute.
The video of this timely podcast can be viewed here:
https://mcgillnews.mcgill.ca/are-mrna-vaccines-the-future-of-cancer-therapy/
Merci Thomas!

Author

Mark Bayfield